Bimatoprost: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
Baris 102:
Bimatoprost disetujui untuk penggunaan medis di Amerika Serikat pada tahun 2001.<ref name=AHFS2019/> Obat ini tersedia sebagai obat generik.<ref name=BNF76>{{cite book|title=British national formulary : BNF 76|date=2018|publisher=Pharmaceutical Press|isbn=9780857113382|pages=1149|edition=76}}</ref><ref name="Bimatoprost label" /><ref>{{cite web | title=Bimatoprost | website=Drugs.com | date=2 December 2019 | url=https://www.drugs.com/international/bimatoprost.html | access-date=4 January 2020}}</ref>
==Kegunaan==
==Efek samping==
==Interaksi==
==Farmakologi==
==Penelitian==
==Referensi==
== Bacaan lebih lanjut ==
* {{cite journal | vauthors = | title = Prostaglandin Analogues for Ophthalmic Use: A Review of the Comparative Clinical Effectiveness and Cost-Effectiveness | journal = CADTH Rapid Response Reports | date = July 2015 | pmid = 26985536 }}
{{Portal bar | Medicine}}
[[Category:Cosmetics chemicals]]
[[Category:Hair loss medications]]
[[Category:Ophthalmology drugs]]
[[Category:Prostaglandins]]
[[Category:Drugs developed by AbbVie]]
[[Category:Wikipedia medicine articles ready to translate]]
| |||